The global market for Gastrointestinal (GI) Endoscopy Devices is estimated at US$35.2 Billion in 2023 and is projected to reach US$49.9 Billion by 2030, growing at a CAGR of 5.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the GI endoscopy devices market is driven by several factors, including technological advancements, the rising incidence of gastrointestinal diseases, and the growing preference for minimally invasive procedures. Technological innovations have played a pivotal role, with the integration of artificial intelligence in endoscopic imaging significantly enhancing diagnostic accuracy and speed, allowing for more precise detection of abnormalities. The development of disposable endoscopes has also been a major advancement, reducing the risk of cross-contamination and infection, which has further boosted their adoption in clinical settings. The increasing prevalence of colorectal cancer and other gastrointestinal cancers has underscored the need for regular screenings, contributing significantly to market growth. Additionally, lifestyle changes, such as poor dietary habits and sedentary lifestyles, have led to a surge in gastrointestinal disorders, thereby driving demand for endoscopic procedures. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising healthcare expenditures are creating new growth opportunities for the GI endoscopy devices market. As more regions gain access to advanced diagnostic tools and treatments, the demand for GI endoscopy devices is expected to continue its upward trajectory, driven by the need for effective, minimally invasive diagnostic and therapeutic solutions.
The growth in the GI endoscopy devices market is driven by several factors, including technological advancements, the rising incidence of gastrointestinal diseases, and the growing preference for minimally invasive procedures. Technological innovations have played a pivotal role, with the integration of artificial intelligence in endoscopic imaging significantly enhancing diagnostic accuracy and speed, allowing for more precise detection of abnormalities. The development of disposable endoscopes has also been a major advancement, reducing the risk of cross-contamination and infection, which has further boosted their adoption in clinical settings. The increasing prevalence of colorectal cancer and other gastrointestinal cancers has underscored the need for regular screenings, contributing significantly to market growth. Additionally, lifestyle changes, such as poor dietary habits and sedentary lifestyles, have led to a surge in gastrointestinal disorders, thereby driving demand for endoscopic procedures. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising healthcare expenditures are creating new growth opportunities for the GI endoscopy devices market. As more regions gain access to advanced diagnostic tools and treatments, the demand for GI endoscopy devices is expected to continue its upward trajectory, driven by the need for effective, minimally invasive diagnostic and therapeutic solutions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Endoscopic Retrograde Cholangiopancreatography Devices (ERCP) segment, which is expected to reach US$25.5 Billion by 2030 with a CAGR of a 5.3%. The Capsule Endoscopes segment is also set to grow at 5.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $9.5 Billion in 2023, and China, forecasted to grow at an impressive 8.6% CAGR to reach $10.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Gastrointestinal (GI) Endoscopy Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Gastrointestinal (GI) Endoscopy Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Gastrointestinal (GI) Endoscopy Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Nutrition, Boston Scientific Corporation, Cardinal Health, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 32 Featured):
- Abbott Nutrition
- Boston Scientific Corporation
- Cardinal Health, Inc.
- ConMed Corporation
- Cook Medical, Inc.
- Erbe Elektromedizin GmbH
- Johnson & Johnson
- Kimberly-Clark Corporation
- Medtronic, Inc.
- Olympus Corporation
- Ricoh Imaging Co., Ltd.
- Stryker Corporation
- Taewoong Medical Co., Ltd.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Nutrition
- Boston Scientific Corporation
- Cardinal Health, Inc.
- ConMed Corporation
- Cook Medical, Inc.
- Erbe Elektromedizin GmbH
- Johnson & Johnson
- Kimberly-Clark Corporation
- Medtronic, Inc.
- Olympus Corporation
- Ricoh Imaging Co., Ltd.
- Stryker Corporation
- Taewoong Medical Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 169 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 35.2 Billion |
| Forecasted Market Value ( USD | $ 49.9 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
